Jinxin Fertility maintains capital, plans significant option grants

Jinxin Fertility Group Limited reported a stable authorized/registered share capital of $50,000 for the month ended September 30, 2025. This figure is based on 5bn ordinary shares with a par value of $0.00001 per share. The company's issued share capital also remained unchanged, with 2,744,706,043 ordinary shares outstanding and 13m treasury shares, totaling 2,757,706,043 issued shares.

The company announced conditional grants approved by its Board on September 25, 2025, contingent on the 2025 Share Scheme taking effect. These grants include 137.235m options to management grantees and 2.4m options along with 1.2m restricted shares to non-executive grantees. Notably, the conditional grant to Mr. Dong Yang requires further approval from independent shareholders at an EGM.

These proposed movements in options and restricted shares highlight the company's strategic remuneration plans, subject to shareholder approval for the 2025 Share Scheme. No new shares were issued or transferred out of treasury during September 2025 in connection with these agreements.